中文名 | Fuzuloparib |
英文名 | 4-(4-fluoro-3-(2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl)benzyl)phthalazin-1(2H)-one |
别名 | 氟唑帕利 化合物FLUZOPARIB 氟唑帕利(SHR-3162) |
英文别名 | HS10160 Fuzuopali Fluzoparib Fuzuloparib 4-(4-fluoro-3-(2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl)benzyl)phthalazin-1(2H)-one 1(2H)-Phthalazinone, 4-[[3-[[5,6-dihydro-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrazin-7(8H)-yl]carbonyl]-4-fluorophenyl]methyl]- |
CAS | 1358715-18-0 |
化学式 | C22H16F4N6O2 |
分子量 | 472.4 |
溶解度 | 溶于DMSO |
存储条件 | -20℃ |
上游原料 | 5-溴-2-氟苯甲酸 2-(三氟甲基)-[1,2,4]噻唑并[1,5-A]吡嗪 2-(三氟甲基)-5,6,7,8-四氢-[1,2,4]三唑并[1,5-A]吡嗪 |
参考资料 展开查看 | 1: Jiang X, Tao Y, Liu Y, Shi P, Li T, Sun F, Cao Y, Wang C. A Randomized, Open- label, Two-period Crossover Bridging Study on Fuzuloparib Capsules of Different Specifications in Healthy Chinese Volunteers. Br J Clin Pharmacol. 2021 Aug 10. doi: 10.1111/bcp.15035. Epub ahead of print. PMID: 34378245. 2: Lee A. Correction to: Fuzuloparib: First Approval. Drugs. 2021 Jul;81(10):1227. doi: 10.1007/s40265-021-01570-6. Erratum for: Drugs. 2021 Jul;81(10):1221-1226. PMID: 34245448. 3: Lee A. Fuzuloparib: First Approval. Drugs. 2021 Jul;81(10):1221-1226. doi: 10.1007/s40265-021-01541-x. Erratum in: Drugs. 2021 Jul 10;: PMID: 34118019. 4: Zhang Q, Kai J, Zhai Y, Xu N, Shentu J, Zhang Y, Liang Y, Wang Y, Wu L. The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers. Br J Clin Pharmacol. 2021 May 25. doi: 10.1111/bcp.14926. Epub ahead of print. PMID: 34033139. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.117 ml | 10.584 ml | 21.168 ml |
5 mM | 0.423 ml | 2.117 ml | 4.234 ml |
10 mM | 0.212 ml | 1.058 ml | 2.117 ml |
5 mM | 0.042 ml | 0.212 ml | 0.423 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!